https://www.live-feeds.com/feed/fda-again-bypasses-advisers-to-remove-black-box-warnings-from-menopause-treatmentsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/fda-again-bypasses-advisers-to-remove-black-box-warnings-from-menopause-treatmentshttps://www.live-feeds.com/feed/fda-again-bypasses-advisers-to-remove-black-box-warnings-from-menopause-treatments#u181487Fri, 06 Nov 2026 14:11:49 +0000The Food and Drug Administration approved the removal of the strictest black-box warnings from three estradiol transdermal patches used to treat menopause symptoms. The October 30 update follows previous labeling changes on February 12, 2026, which removed safety warnings from six other menopausal hormone therapy products. The updated labels strip away previous warnings regarding cardiovascular disease, breast cancer, and probable dementia, though other clinical precautions remain in place. The latest regulatory shift occurred while women across the United States face an ongoing estrogen patch